Parenteral Drugs (India) Limited
Share Price Target & Analysis
NSE:PDPL
VWAP
Open
Close
High
Low
52 Week High
0.00 (0%)
PDPL
(PHARMA)Watch Carefully
52 Week Low
EPS
PE
PB
Uncertain
Quality
Unclear
Valuation
#Analysis
NSE: PDPL Share Price Financial Analysis & Valuation
Parenteral Drugs (India) Limited (PDPL) is broadly categorized in PHARMA segment industry which deals in Pharmaceuticals vertical.
It is one of Penny Stocks company with Market Capitalization of Rs 11.8 (in Cr). Total number of free float shares are 3 (in Lacs).
Parenteral Drugs (India) Limited is listed on NSE with Exchange ID - INE904D01019 and trading code is NSE:PDPL with short name Parenteral Drug.
In the past 1 year, Parenteral Drugs (India) Limited has declared an equity dividend of Rs 0 per share. At the current share price of PDPL at Rs 2.90, this results in a dividend yield of 0 %.
As per the Fundamental Analysis of NSE:PDPL, which uses revenues, earnings, future growth, financial ratios, return on equity, profit margins, and other data to determine PDPL underlying value and future prospects. All of this data is available in PDPL financial statements.
Quality of the Stock: As per the fundamental analysis of NSE:PDPL, it is clearly understood that PDPL is Uncertain performer in terms of earnings and profit margins with an EPS of 0.
Valuation of the Stock: The current valuation of PDPL stock is like Unclear which means currently the stock is Confusing. Now, it's totally depends upon the risk appetite of an investor and risk-reward ratio of PDPL whether to BUY this stock at current valuation.
Now, the main question is whether to BUY or SELL, NSE:PDPL at current valuation.
As per latest Analysis No. #724:-
⇑ STRONG BUY PDPL if All Greens
⇗ BUY PDPL (at Lower Levels) if any 2 Greens
⇒ NEUTRAL or HOLD PDPL (With Stop Loss) if only 1 Green
⇘ SELL PDPL if NO Green Indicator
NSE: PDPL Share Price Today (Nov 23, 2024)
(Parenteral Drugs (India) Limited Daily Analysis on the basis of PDPL Intraday Graph & Trend)
Parenteral Drugs (India) Limited share price moved Down by 0% from its previous close of Rs 2.9. PDPL stock last traded price is 2.90. PDPL share price trend is Down with a total of 1063 stocks traded till now. It has touched an intraday high of Rs 2.9 and an intraday low of Rs 2.7. The PDPL trading at 2.90, Down by Rs. 0.00, or 0 percent which suggests that most of the Traders are anticipating that the price of PDPL share should go Down.
NSE: PDPL Share Price Tomorrow Prediction
(Parenteral Drugs (India) Limited Share Price Prediction for Tomorrow & future forecast is based on Current Trend of PDPL)
Parenteral Drugs (India) Limited share price moved Down by 0%. PDPL share price short term trend is Down. It suggests that PDPL Share Price for Tomorrow remains the same with VWAP at 2.86 will be treated as stop loss for intraday traders. Parenteral Drugs (India) Limited Long term investors can follow the PDPL long term trend as mentiond in future forecast table.
NSE Code |
NSE: PDPL |
PDPL Share Price Today |
2.90 |
PDPL Share Price Target Prediction for 2024 ^ |
2.8 - 4 |
PDPL Share Price Target Prediction for 2025*^ |
4 - 4.2 |
PDPL Share Price Target Prediction for 2026*^ |
4.2 - 4.4 |
PDPL Share Price Target Prediction for 2027*^ |
5 |
PDPL Share Price Target Prediction for 2028*^ |
5 |
PDPL Share Price Target Prediction for 2030*^ |
5 |
PDPL Current Book Value 2023 |
Data Not Available |
*Parenteral Drugs (India) Limited Short Term & Long Term share price target is based on current financial year earings of the company.
^PDPL share price target prediction for 2024 2025 & 2026 to 2030 is based on current market scenario, future forecast & growth assumptions, they might change subject to market sentiments.
PDPL Technical Analysis (In Process... .. .)
Please wait for a while and refresh the page to check again.
Most popular Questions & Answers about PDPL
Parenteral Drugs (India) Limited stock last traded price is 2.90. PDPL share price moved Down by 0% from its previous close of Rs 2.9.
Parenteral Drugs (India) Limited share price trend is Down with a total of 1063 stocks traded till now. It has touched an intraday high of Rs 4.848 and an intraday low of Rs 2.7. The PDPL trading at 2.90, Down by Rs. 0.00, or 0 percent which suggests that most of the Traders are anticipating that the price of PDPL share should go Down and the Stop Loss will be around 2.86.
The market cap of Parenteral Drugs (India) Limited is ₹11.8 (in Cr) as of Nov 22, 2024.
The current price to earning ratio for Parenteral Drugs (India) Limited as of Nov 22, 2024 is 44.47.
The current price to book ratio for Parenteral Drugs (India) Limited as of Nov 22, 2024 is N/A.
The highest price of Parenteral Drugs (India) Limited stock is ₹4.8 in the last 52-week.
The lowest price of Parenteral Drugs (India) Limited stock is ₹2.7 in the last 52-week.
Parenteral Drugs (India) Limited share trading at ₹2.90, Down by Rs. 0.00, or 0 percent which suggests that most of the traders are anticipating that the price of PDPL share should go Down.
In 2023, Stock price target for Parenteral Drugs (India) Limited (PDPL) are ₹2.8 on downside and ₹4 on upside. Parenteral Drugs (India) Limited share price target is based on current financial year earings of the company.
In 2024, Stock price target for Parenteral Drugs (India) Limited (PDPL) are ₹4 on downside and ₹4.2 on upside. Parenteral Drugs (India) Limited share price target is based on forecasted future earnings of the company.
In 2025, Stock price target for Parenteral Drugs (India) Limited (PDPL) are ₹4.2 on downside and ₹4.4 on upside. Parenteral Drugs (India) Limited share price target is based on Discounted Cash Flow (DCF) method uses the projected future cash flows of the business.
In next five years, Stock price target for Parenteral Drugs (India) Limited (PDPL) will be around ₹5 Parenteral Drugs (India) Limited share price target is based on market scenario & growth assumptions, they might change subject to market sentiments and forecasted future earnings of PDPL.
The price of Parenteral Drugs (India) Limited (PDPL) shares moved by 0%. The short-term trend for PDPL share price is Down. It implies that the share price of PDPL will stay the same tomorrow and that intraday traders should treat VWAP at 2.86 as a stop loss. Investors with a long-term outlook can track PDPL long-term trajectory, which is indicated in the future forecast table.
Estimated DCF Value of PDPL stock is Unavailable at this moment. Compared to the current market price of 2.90 INR, the PDPL stock is unpredictable by lack of Insufficient data.
As per the fundamental analysis of Parenteral Drugs (India) Limited (PDPL), it is of Uncertain quality in terms of earnings and profit margins with an EPS of 0.
NSE:PDPL News & Other Useful Information about PDPL Share Price
Peer Comparison of NSE: PDPL
The Peers list includes companies operating in the same industry and having comparable market cap.
Sector: Pharmaceuticals
Company | Price | EPS | BV |
---|---|---|---|
SUNPHARMA | 1805.60 | 11.21 | 98.75 |
DIVISLAB | 6000.00 | 69.2 | 507.94 |
MEDICAMEQ | 446.75 | 8.18 | 164.54 |
CIPLA | 1485.25 | 54.32 | 346.38 |
DRREDDY | 1214.00 | 57.64 | 290.52 |
PGHH | 15925.70 | 189.8 | 324.25 |
TORNTPHARM | 3171.00 | 48.34 | 201.78 |
BIOCON | 331.60 | 0.35 | 90.88 |
LUPIN | 2064.55 | 65.71 | 451.63 |
ALKEM | 5583.35 | 176.48 | 882.75 |